Uncategorized

Criteria for COVID-19 Isolation and Designated Unit Placement

Based on CDC and ODH criteria, the following patients should be admitted to a designated unit for COVID-19: 

  • Any patient with onset of symptoms or initial COVID-19 positive test within 10 days of admission 
  • Patients with a negative rapid SARS-CoV-2 test but a strong suspicion of COVID-19 (and no alternate diagnosis) while awaiting PCR results—NOCC to escalate to Drs. Weinstein or Lytle 
  • Patients with severe-critical* COVID-19 or who are severely immunosuppressed* who are still febrile or have worsening respiratory symptoms with no alternate diagnosis and are 10-20 days from onset of symptoms or initial positive COVID-19 test—NOCC to escalate to Drs. Weinstein or Lytle 

The following patients do not require admission to a designated unit for COVID-19: 

  • Patients with mild-moderate disease with initial onset of symptoms or a positive test 10 or more days prior to admission 
  • Any patient including those who are severe, critical, or severely immunosuppressed* with initial onset of symptoms or a positive test >20 days prior to admission and <90 days prior to admission 

Definitions: 

Mild illness: Fever, cough, malaise without shortness of breath or abnormal CXR 

Moderate illness: Evidence of lower respiratory tract disease by assessment or imaging and O2 sat > 94% on room air 

Severe illness:  Respiratory rate > 30, room air O2 sat <94%, (or, for patients with chronic hypoxemia, a decrease from baseline of >3%), PO2/FiO2 ratio <300, or lung infiltrates of >50% 

Critical illness: Respiratory failure, septic shock, or multiple organ dysfunction 

* Severely immunocompromised: 

                Cancer chemotherapy, < 1 yr from stem cell or organ transplant, untreated HIV/AIDS with CD4 <200, combined primary immunodeficiency disorder, prednisone > 20 mg/day x >14 days. 

December 2, 2020